CHASE PHARMACEUTICALS CORP

Profile

Company Names

CHASE PHARMACEUTICALS CORP

Addresses

1825 K STREET, NW, SUITE 510, WASHINGTON, DC, DC 20006

1825 K STREET, NW, SUITE 510, WASHINGTON, DC 20006

1823 K STREET, NW, SUITE 520, WASHINGTON, DC 20006

1825 K STREET NW, SUITE 520, WASHINGTON, DC 20006

1825 K STREET, NW, SUITE 520, WASHINGTON, DC 20006

Phone Numbers

202-792-4621
202-223-7002

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$22,812,003.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2016-03-14 
$11,974,004.00 
$11,974,004.00 
$0.00 
Equity 
5
2016-01-13 
$0.00 
$612,500.00 
$612,500.00 
Equity 
4
2015-12-11 
$0.00 
$106,650.00 
$106,650.00 
Equity 
3
2015-08-05 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
2
2014-05-09 
$6,137,999.00 
$8,586,000.00 
$2,448,001.00 
Equity 
1
2010-11-23 
$1,200,000.00 
$1,200,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
N. 
CHASE 
EXECUTIVE OFFICER, DIRECTOR
KATHLEEN 
 
CLARENCE-SMITH 
EXECUTIVE OFFICER, DIRECTOR
STEPHEN 
 
CUNNINGHAM 
DIRECTOR
RICHARD 
P. 
DULIK 
EXECUTIVE OFFICER
DOUGLAS 
 
INGRAM 
DIRECTOR, EXECUTIVE OFFICER
GREG 
N. 
PAREKH 
DIRECTOR
N. 
GREG 
PAREKH 
DIRECTOR
NAYAN 
GREG 
PAREKH 
DIRECTOR
JOHN 
REHER 
DIRECTOR
JOHN 
M. 
REHER 
DIRECTOR, EXECUTIVE OFFICER
JOHN 
M. 
SIEBERT 
EXECUTIVE OFFICER, DIRECTOR
VIKRAM 
 
SUDARSAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-14 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-05 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-13 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-05 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#